Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.
Knowledge for Growth - Postponed to September
Novosanis team members will attend the Knowledge for Growth congress in Ghent, Belgium; which will take place on 10 September 2020. Our team is excited to meet you there and give you more information about our unique urine capturing device Colli-Pee. This info will be shared by presenting a poster...